Tag: insulin

June 10, 2018

5 Top Weekly NASDAQ Biotech Stocks: Caladrius Soars 77 Percent

Caladrius Biosciences, Bellerophon Therapeutics, Celsion, Albireo Pharma and Trillium Therapeutics were last week's top gainers on the NASDAQ Biotechnology Index.
June 10, 2018

5 Top Weekly NASDAQ Biotech Stocks: MEI Pharma on Top

MEI Pharma, Anavex Life Sciences, Trillium Therapeutics, Celldex Therapeutics and Ophthotech were last week's top gainers on the NASDAQ Biotechnology...
May 29, 2018

10 Top Pharmaceutical Companies

Here we take a look at the top 10 largest pharmaceutical companies dominating the industry to give investors insight.
May 13, 2018

5 Top Weekly NASDAQ Biotech Stocks: Helius Up 43.19 Percent

Helius Medical Technologies, vTv Therapeutics, Second Sight Medical Products, Depomed and Senomyx were last week's top gainers on the NASDAQ.
April 29, 2018

5 Top Weekly NASDAQ Biotech Stocks: Eleven Biotherapeutics Up 45 Percent

Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ.
April 26, 2018

FDA Determines that Afrezza REMS Communication Plan Has Met Goals and REMS No Longer Necessary

MannKind (Nasdaq:MNKD), focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and...
April 23, 2018

Lexaria Announces Human Clinical Study on CBD Absorption Underway

Lexaria Bioscience Corp. (CSE:LXX,OTCQB:LXRP), a drug delivery platform innovator, is pleased to announce that it has commenced a clinical study...
April 15, 2018

5 Top Weekly NASDAQ Biotech Stocks: Novelion on Top

Novelion Therapeutics, EyePoint Pharmaceuticals, CytRx, Viking Therapeutics and AVEO Pharmaceuticals were last week's top gainers.
April 1, 2018

5 Top NASDAQ Biotech Stocks: Cardiome on Top

Cardiome, Avid, XBiotech, Fennec and Compugen were last week's five top-gaining NASDAQ biotech stocks. See what moved their share prices.
March 26, 2018

Lexicon Pharmaceuticals Announces Regulatory Submissions for Sotagliflozin to Treat Adults With Type 1 Diabetes

Lexicon Pharmaceuticals (Nasdaq:LXRX) announced that its collaborator, Sanofi, has submitted a New Drug Application (NDA) to the U.S. Food and Drug...